The global OTC cold and cough medicines market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Increased incidence of respiratory distress and increased air pollution are some of the key factors contributing to the growth of the OTC cold and cough medicines market. Additionally, the market is expected to see positive growth due to increased product development. Rising number of geriatric population are accustomed to coughing and cold, increased car pollution, increased demand for commodities, development of R&D activities are some of the major factors driving the market growth. The growing number of cough cases, the development of high-quality products, and the use of effective treatments are set to further enhance the market demand for cough products during the forecast period.
According to the World Health Organization (WHO), in 2019, Asthma affected an estimated 262 million people worldwide and was responsible for an estimated 461000 mortalities. Bronchodilators are medicines that open the airways to treat asthma and help clear the mucus from the lungs. The growing percentage of people who are unable to protect themselves from disease, the rising demand for OTC antimicrobials, and expectorants. Additionally, the growth of the global OTC cold and cough medicine market is attributed to an increased number of patients using self-medication. According to a self-administered study, published in February 2019, in BMC Public Health 93.7% of participants had taken OTC medication. Many OTC medications that are commonly taken in the cold are antihistamines, antipyretics, and preparations for colds and coughs.
(Get 15% Discount on Buying this Report)
Get Sample Copy of Global OTC Cold and Cough Medicines Market at https://orionmarketreports.com/request-sample/?id=94328&submit=Request+Sample%0D%0A
Market Coverage
- The market number available for – 2021-2028
- Base year- 2021
- Forecast period- 2022-2028
- Segment Covered-
- By Drug Type
- By Formulation
- Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape– AstraZeneca Plc., GlaxoSmithKline Plc., Novartis AG,Pfizer Inc., and Prestige Brands Holdings Inc.,among others.
A full report is available at: https://orionmarketreports.com/global-otc-cold-and-cough-medicines-market/94328/
Global OTC Cold and Cough Medicines Market Report by Segment
By Drug Type
- Antihistamines
- Expectorants
- Antibiotics
- Others
By Formulation
- Oral Syrups
- Tablets/ Pills
- Nasal Drops
- Lozenges
- Others
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How has COVID-19 impacted the market?
- Deviation from the pre-COVID-19 forecast
- Most affected region and segment
- Who is the leader in the market?
- How players are addressing challenges to sustain growth?
- Where is the investment opportunity?
About Us:
Orion Market Reports (OMR) endeavors to provide exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.
Media Contact:
Company Name: Orion Market Reports
Contact Person: Mr. Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +91 780-304-0404
